2m 2m 2m 2m 2m 2m 2m
IGC Pharma (IGC)
NYSE
$0.27+$0.002 (+0.79%)
Price as of Jul 14, 2026 4:52 AM EDT- $28.4MMarket Cap
- -29.04%1-Year Change
- BiotechnologyIndustry
IGC Pharma (IGC)
$0.27+$0.002 (+0.79%)
IGC | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.27 | ||
Change | -$0.006 (-2.24%) | ||
Open | $0.27 | ||
High | $0.28 | ||
Low | $0.26 | ||
Previous Close | $0.27 | ||
Volume | 512,204 | ||
30-Day Average Volume | 544,282 | ||
1-Week Change | -5.37% | ||
1-Month Change | -5.04% | ||
1-Year Change | -29.04% | ||
3-Year Change | -31.82% | ||
5-Year Change | -82.03% | ||
Fundamentals | |||
Shares Outstanding | 104.4M | ||
Total Assets | $9.2M | ||
Market Cap | $28.4M | ||
Enterprise Value | $29.1M | ||
Period: QTR TTM FY | |||
Revenue | $317,000.00 | ||
Net Income | -$2.4M | ||
Free Cash Flow | -$1.2M | ||
EBIT | -$2.4M | ||
EBITDA | -$2.3M | ||
Net Working Capital | -$1.7M | ||
EPS | -$0.02 | ||
Enterprise Value/EBITDA | -12 | ||
Enterprise Value/Revenue | 92 | ||
P/B | 5 | ||
P/E | -14 | ||
PEG | 0 | ||
Price/Free Cash Flow | -23 | ||
Price/Operating Cash Flow | -23 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 10 | ||
Last Split Date | 04/19/2013 | ||
Earnings & Revenue